SynthesisJournal of managed care & specialty pharmacy2017

A Systematic Review of U.S. Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding?

Anna Hung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.